All Stories

  1. Phase 3, single-arm, multicenter study of dabigatran etexilate for secondary prevention of venous thromboembolism in children: Rationale and design
  2. Phase IIa study of dabigatran etexilate in children with venous thrombosis: pharmacokinetics, safety, and tolerability
  3. Increased plasminogen activator inhibitor results in a hypofibrinolytic state in adolescents with obesity:in vivoandex vivoevidence
  4. Central venous catheter-related thrombosis and thromboprophylaxis in children: a systematic review and meta-analysis: discussion